A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 972-978

  Faratian, D ^a   Stillie, A ^b   Busby Earle, R M C ^c   Cowie, V J ^b   Monaghan, H ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Chemotherapy; Papillary; Radiotherapy; Serous; Uterus

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL RECORD; MIXED TUMOR; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; UNIVARIATE ANALYSIS; UTERUS CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALPINGOSTOMY; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 33745094974     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00576.x     Document Type: Article

References (30)

1. Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med 1981 105 : 615 8.
2. Hendrickson M Ross J Eifel PJ Cox RS Martinez A Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol 1982 13 : 373 92.
3. Hendrickson M Ross J Eifel P Martinez A Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982 6 : 93 108.
4. Barakat RR Wong G Curtin JP Vlamis V Hoskins WJ. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 1994 55 : 164 8.
5. Magriples U Naftolin F Schwartz PE Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993 11 : 485 90.
6. Geisler JP Sorosky JI Duong HL et al. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma. Gynecol Oncol 2001 83 : 501 3.
7. Goshen R Chu W Elit L et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000 79 : 477 81.
8. Lavie O Hornreich G Ben Arie A et al. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. Gynecol Oncol 2004 92 : 521 4.
9. Goff BA Kato D Schmidt RA et al. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994 54 : 264 8.
10. Christman JE Kapp DS Hendrickson MR Howes AE Ballon SC. Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report. Gynecol Oncol 1987 26 : 228 35.
11. Walker AN Mills SE. Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases. Diagn Gynecol Obstet 1982 4 : 261 7.
12. Sherman ME Bitterman P Rosenshein NB Delgado G Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992 16 : 600 10.
13. Abeler VM Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol 1990 39 : 266 71.
14. Carcangiu ML Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992 47 : 298 305.
15. Chambers JT Merino M Kohorn EI Peschel RE Schwartz PE. Uterine papillary serous carcinoma. Obstet Gynecol 1987 69 : 109 13.
16. Christopherson WM Alberhasky RC Connelly PJ. Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study, 46 cases. Am J Clin Pathol 1982 77 : 534 40.
17. Slomovitz BM Burke TW Eifel PJ et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 2003 91 : 463 9.
18. Sykiotis K Kondi-Pafiti A Giannaris D Kouvaris J Papayannopoulou A Salamalekis E. Uterine serous papillary carcinoma clinical and immunopathological study of 9 cases. Eur J Gynaecol Oncol 2001 22 : 456 8.
19. Dunton CJ Balsara G McFarland M Hernandez E. Uterine papillary serous carcinoma: a review. Obstet Gynecol Surv 1991 46 : 97 102.
20. Bristow RE Asrari F Trimble EL Montz FJ. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol Oncol 2001 81 : 279 86.
21. Tay EH Ward BG. The treatment of uterine papillary serous carcinoma (UPSC): are we doing the right thing?. Int J Gynecol Cancer 1999 9 : 463 9.
22. Kelly MG O'malley DM Hui P et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 2005 98 : 353 9.
23. Nicklin JL Copeland LJ. Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol 1996 39 : 686 95.
24. Gehrig PA Van Le L Fowler WC Jr. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 2003 13 : 212 5.
25. Huh WK Powell M Leath CA III. et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 2003 91 : 470 5.
26. Ramondetta L Burke TW Levenback C Bevers M Bodurka-Bevers D Gershenson DM. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol 2001 82 : 156 61.
27. Zanotti KM Belinson JL Kennedy AW Webster KD Markman M. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecol Oncol 1999 74 : 272 7.
28. Sood BM Jones J Gupta S et al. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2003 57 : 208 16.
29. Mallipeddi P Kapp DS Teng NN. Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer 1993 71 : 3076 81.
30. Frank AH Tseng PC Haffty BG et al. Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma. Cancer 1991 68 : 1516 9.